Search Results - "Law, Lee"

Erlotinib-loaded carboxymethyl temarind gum semi-interpenetrating nanocomposites by Bera, Hriday, Abbasi, Yasir Faraz, Lee Ping, Law, Marbaniang, Daphisha, Mazumder, Bhaskar, Kumar, Pramod, Tambe, Prajakta, Gajbhiye, Virendra, Cun, Dongmei, Yang, Mingshi

“…[Display omitted] •CMTG-g-PNIPA-MMT based semi-IPN NCs was synthesized.•It depicted excellent biodegradability and pH/temperature-dependent swelling.•ERL was…”
Get full text

MicroRNAs and extracellular vesicles in cholangiopathies by Olaizola, P., Lee-Law, P.Y., Arbelaiz, A., Lapitz, A., Perugorria, M.J., Bujanda, L., Banales, J.M.

“…Cholangiopathies encompass a heterogeneous group of disorders affecting biliary epithelial cells (i.e. cholangiocytes). Early diagnosis, prognosis and…”
Get full text

Synthetic Conjugates of Ursodeoxycholic Acid Inhibit Cystogenesis in Experimental Models of Polycystic Liver Disease by Caballero‐Camino, Francisco J., Rivilla, Ivan, Herraez, Elisa, Briz, Oscar, Santos‐Laso, Alvaro, Izquierdo‐Sanchez, Laura, Lee‐Law, Pui Y., Rodrigues, Pedro M., Munoz‐Garrido, Patricia, Jin, Sujeong, Peixoto, Estanislao, Richard, Seth, Gradilone, Sergio A., Perugorria, Maria J., Esteller, Manel, Bujanda, Luis, Marin, Jose J.G., Banales, Jesus M., Cossío, Fernando P.

“…Background and Aims Polycystic liver diseases (PLDs) are genetic disorders characterized by progressive development of symptomatic biliary cysts. Current…”
Get full text

Multiple Wnts are involved in Hydra organizer formation and regeneration by Lengfeld, Tobias, Watanabe, Hiroshi, Simakov, Oleg, Lindgens, Dirk, Gee, Lydia, Law, Lee, Schmidt, Heiko A., Özbek, Suat, Bode, Hans, Holstein, Thomas W.

“…Wnt genes and β-Catenin signaling are involved in axial patterning processes in vertebrate embryogenesis in setting up the Spemann–Mangold organizer in…”
Get full text

Targeting UBC9-mediated protein hyper-SUMOylation in cystic cholangiocytes halts polycystic liver disease in experimental models by Lee-Law, Pui Y., Olaizola, Paula, Caballero-Camino, Francisco J., Izquierdo-Sanchez, Laura, Rodrigues, Pedro M., Santos-Laso, Alvaro, Azkargorta, Mikel, Elortza, Felix, Martinez-Chantar, Maria L., Perugorria, Maria J., Aspichueta, Patricia, Marzioni, Marco, LaRusso, Nicholas F., Bujanda, Luis, Drenth, Joost P.H., Banales, Jesus M.

“…Polycystic liver diseases (PLDs) are genetic disorders characterized by progressive development of multiple fluid-filled biliary cysts. Most PLD-causative…”
Get full text

New Advances in Polycystic Liver Diseases by Santos-Laso, A, Izquierdo-Sánchez, L, Lee-Law, P Y, Perugorria, M J, Marzioni, M, Marin, J J G, Bujanda, L, Banales, J M

“…Polycystic liver diseases (PLDs) include a heterogeneous group of congenital disorders inherited as dominant or recessive genetic traits; they are manifested…”
Get more information

Inhibition of NAE‐dependent protein hyper‐NEDDylation in cystic cholangiocytes halts cystogenesis in experimental models of polycystic liver disease by Lee‐Law, Pui Y., Olaizola, Paula, Caballero‐Camino, Francisco J., Izquierdo‐Sanchez, Laura, Rodrigues, Pedro M., Perugorria, Maria J., Azkargorta, Mikel, Elortza, Felix, Martinez‐Chantar, Maria L., Aspichueta, Patricia, Marzioni, Marco, Bujanda, Luis, Drenth, Joost P. H., Banales, Jesus M.

“…Background Polycystic liver diseases (PLDs) are genetic inherited disorders characterized by the progressive growth of numerous intrahepatic biliary cysts,…”
Get full text

Genetics of polycystic liver diseases by Lee-Law, Pui Y, van de Laarschot, Liyanne F.M, Banales, Jesus M, Drenth, Joost P.H

“…PURPOSE OF REVIEWThis review provides an outline of the most recent insights and significant discoveries regarding the genetic mechanisms involved in…”
Get full text

Barriers And Challenges Of Multidisciplinary Teams In Oncology Management: A Scoping Review Protocol by Law, Nicholas Lee Wei, Hong, Lai Wei, Tan, Shirley Siang Ning, Foo, Chuan Jie, Lee, Daniel, Voon, Pei Jye

“…IntroductionMultidisciplinary teams (MDTs) are integral to oncology management, involving specialised healthcare professionals who collaborate to develop…”
Get full text

Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models by Olaizola, Paula, Lee-Law, Pui Yuen, Fernandez-Barrena, Maite G, Alvarez, Laura, Cadamuro, Massimiliano, Azkargorta, Mikel, O'Rourke, Colm J, Caballero-Camino, Francisco J, Olaizola, Irene, Macias, Rocio I R, Marin, Jose J G, Serrano-Maciá, Marina, Martinez-Chantar, Maria L, Avila, Matias A, Aspichueta, Patricia, Calvisi, Diego F, Evert, Matthias, Fabris, Luca, Castro, Rui E, Elortza, Felix, Andersen, Jesper B, Bujanda, Luis, Rodrigues, Pedro M, Perugorria, Maria J, Banales, Jesus M

“…Cholangiocarcinoma (CCA) comprises a heterogeneous group of malignant tumors associated with dismal prognosis. Alterations in post-translational modifications…”
Get full text

Improving alginate-poly-L-ornithine-alginate capsule biocompatibility through genipin crosslinking by Hillberg, Anna L., Kathirgamanathan, Kalyani, Lam, Janice B. B., Law, Lee Yong, Garkavenko, Olga, Elliott, Robert B.

“…DIABECELL® capsules comprise an inner core of alginate (Alg) coated with a polycationic polymer, poly‐L‐ornithine (PLO), designed as a stabilizing agent for…”
Get full text

Core-shell structured pullulan based nanocomposites as erlotinib delivery shuttles by Bera, Hriday, Ang, Sher Reen, Chiong, Siew Wen, Chan, Chong Hong, Abbasi, Yasir Faraz, Law, Lee Ping, Chatterjee, Bappadity, Venugopal, Vijayan

“…Anionic biopolymer (sodium alginate/low-methoxyl pectin/gellan gum) coated carboxymethyl pullulan-ZnO nanocomposites encapsulating erlotinib were developed for…”
Get full text

Targeting Connexin43 Expression Accelerates the Rate of Wound Repair by Qiu, Cindy, Coutinho, Petula, Frank, Stefanie, Franke, Susanne, Law, Lee-yong, Martin, Paul, Green, Colin R., Becker, David L.

“…The repair of tissue damage is a key survival process in all organisms and involves the coordinated activation of several cell types. Cell-cell communication…”
Get full text

The anti-inflammatory receptor TREM-2 protects the liver from hepatocellular carcinoma development by Esparza-Baquer, A, Labiano, I, Erice, O, Sharif, O, Oakley, F, Lapitz, A, Olaizola, P, Lee-Law, P.Y, Hijona, E, Jiménez-Agüero, R, Knapp, S, Mann, D.A, Bujanda, L, Banales, J.M, Perugorria, M.J

Get full text

Uncoupling Molecular Testing for SARS-CoV-2 From International Supply Chains by Stanton, Jo-Ann L, O'Brien, Rory, Hall, Richard J, Chernyavtseva, Anastasia, Ha, Hye Jeong, Jelley, Lauren, Mace, Peter D, Klenov, Alexander, Treece, Jackson M, Fraser, John D, Clow, Fiona, Clarke, Lewis, Su, Yongdong, Kurup, Harikrishnan M, Filichev, Vyacheslav V, Rolleston, William, Law, Lee, Rendle, Phillip M, Harris, Lawrence D, Wood, James M, Scully, Thomas W, Ussher, James E, Grant, Jenny, Hore, Timothy A, Moser, Tim V, Harfoot, Rhodri, Lawley, Blair, Quiñones-Mateu, Miguel E, Collins, Patrick, Blaikie, Richard

“…The rapid global rise of COVID-19 from late 2019 caught major manufacturers of RT-qPCR reagents by surprise and threw into sharp focus the heavy reliance of…”
Get full text

The dynamic genome of Hydra by Rokhsar, Daniel S, Steele, Robert E, Chapman, Jarrod A, Kirkness, Ewen F, Simakov, Oleg, Hampson, Steven E, Mitros, Therese, Weinmaier, Thomas, Rattei, Thomas, Balasubramanian, Prakash G, Borman, Jon, Busam, Dana, Disbennett, Kathryn, Pfannkoch, Cynthia, Sumin, Nadezhda, Sutton, Granger G, Viswanathan, Lakshmi Devi, Walenz, Brian, Goodstein, David M, Hellsten, Uffe, Kawashima, Takeshi, Prochnik, Simon E, Putnam, Nicholas H, Shu, Shengquiang, Blumberg, Bruce, Dana, Catherine E, Gee, Lydia, Kibler, Dennis F, Law, Lee, Lindgens, Dirk, Martinez, Daniel E, Peng, Jisong, Wigge, Philip A, Bertulat, Bianca, Guder, Corina, Nakamura, Yukio, Ozbek, Suat, Watanabe, Hiroshi, Khalturin, Konstantin, Hemmrich, Georg, Franke, André, Augustin, René, Fraune, Sebastian, Hayakawa, Eisuke, Hayakawa, Shiho, Hirose, Mamiko, Hwang, Jung Shan, Ikeo, Kazuho, Nishimiya-Fujisawa, Chiemi, Ogura, Atshushi, Takahashi, Toshio, Steinmetz, Patrick R. H, Zhang, Xiaoming, Aufschnaiter, Roland, Eder, Marie-Kristin, Gorny, Anne-Kathrin, Salvenmoser, Willi, Heimberg, Alysha M, Wheeler, Benjamin M, Peterson, Kevin J, Böttger, Angelika, Tischler, Patrick, Wolf, Alexander, Gojobori, Takashi, Remington, Karin A, Strausberg, Robert L, Venter, J. Craig, Technau, Ulrich, Hobmayer, Bert, Bosch, Thomas C. G, Holstein, Thomas W, Fujisawa, Toshitaka, Bode, Hans R, David, Charles N

“…The freshwater cnidarian Hydra was first described in 1702 and has been the object of study for 300 years. Experimental studies of Hydra between 1736 and 1744…”
Get full text

Chemosensitivity assessments of curdlan-doped smart nanocomposites containing erlotinib HCl by Bera, Hriday, Abbasi, Yasir Faraz, Gajbhiye, Virendra, Ping, Law Lee, Salve, Rajesh, Kumar, Pramod, Kesavan, Sevaraj, Shaikh, Sohrab A.

“…Curdlan (CN)-doped montmorillonite/poly(N-isopropylacrylamide-co-N,N′-methylene-bis-acrylamide) [CN/MT/P(NIPA-co-MBA)] smart nanocomposites (NCs) were…”
Get full text

SAT-223 - Therapeutic potential of targeting protein hyper-SUMOylation in cholangiocarcinoma by Olaizola, Paula, Olaizola, Irene, de Ara, Marta Fernandez, Fernandez-Barrena, Maite G, Alvarez, Laura, Azkargorta, Mikel, Rourke, Colm O, Lee-Law, Pui-Yuen, Nova-Camacho, Luiz Miguel, Marin, Jose, Martínez-Chantar, María Luz, Avila, Matías A, Aspichueta, Patricia, Elortza, Felix, Andersen, Jesper, Bujanda, Luis, Rodrigues, Pedro Miguel, Perugorria, María Jesús, Banales, Jesus Maria

Get full text

Therapeutic potential of targeting protein hyper-SUMOylation in cholangiocarcinoma by Olaizola, Paula, Olaizola, Irene, de Ara, Marta Fernandez, Fernandez-Barrena, Maite G, Alvarez, Laura, Azkargorta, Mikel, Rourke, Colm O, Lee-Law, Pui-Yuen, Nova-Camacho, Luiz Miguel, Marin, Jose, Martínez-Chantar, María Luz, Avila, Matías A, Aspichueta, Patricia, Elortza, Felix, Andersen, Jesper, Bujanda, Luis, Rodrigues, Pedro Miguel, Perugorria, María Jesús, Banales, Jesus Maria

Get full text

Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models by Olaizola, Paula, Lee-Law, Pui Yuen, Fernandez-Barrena, Maite G., Alvarez, Laura, Cadamuro, Massimiliano, Azkargorta, Mikel, O’Rourke, Colm J., Caballero-Camino, Francisco J., Olaizola, Irene, Macias, Rocio I.R., Marin, Jose J.G., Serrano-Maciá, Marina, Martinez-Chantar, Maria L., Avila, Matias A., Aspichueta, Patricia, Calvisi, Diego F., Evert, Matthias, Fabris, Luca, Castro, Rui E., Elortza, Felix, Andersen, Jesper B., Bujanda, Luis, Rodrigues, Pedro M., Perugorria, Maria J., Banales, Jesus M.

“…Cholangiocarcinoma (CCA) comprises a heterogeneous group of malignant tumors associated with dismal prognosis. Alterations in post-translational modifications…”
Get full text